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E. Gijs Mast, MD, Lucas V.A. Boersma, MD, PHD, Martijn C. Post, MD, PHDA n 83-year-old man, with a history of perma-nent atrial ﬁbrillation, and an ischemic cere-bral event, was referred for a percutaneous
left atrial appendage (LAA) closure. Because of a
high CHA2DS2-VASC (Congestive heart failure [orFIGURE 1 Standard 12-Lead Electrocardiogram After LAA Closure
The electrocardiogram shows (A) atrial ﬁbrillation with normal conducti
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treated hypertension on medication], Age $75 years,
Diabetes mellitus, previous Stroke or TIA or throm-
boembolism, Vascular disease [e.g., peripheral arteryon and (B) a new intermittent left bundle branch block.
us Hospital, Nieuwegein, the Netherlands. The Car-
ds) receives proctoring fees for training/educational
FIGURE 2 Watchman Device Pushing Against the Interven-
tricular Septum
Mid-esophageal long-axis view showing the Watchman device
(solid arrow) below the mitral valve pushing against the inter-
ventricular septum (Online Video 1). Ao ¼ aorta; LA ¼ left atrium;
LAA ¼ left atrial appendage; LV ¼ left ventricle.
FIGURE 4 Watchman Device Being Pulled Out by a Catheter
Through the Cardiac Apex
Mid-esophageal long-axis view showing the Watchman device
(solid arrow) being pulled out by a catheter through the cardiac
apex (Online Video 3). Abbreviations as in Figure 2.
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e116disease, myocardial infarction, aortic plaque], Age 65
to 74 years, Sex category [e.g., female sex]) score
(5 points) and a strong contraindication for oral anti-
coagulants (HAS-BLED [Hypertension, AbnormalFIGURE 3 Watchman Device Causing Obstruction of the Left
Ventricular Outﬂow Tract and Causing Mitral
Regurgitation
Three-dimensional full volume with color showing the Watchman
device (solid arrow) causing obstruction (turbulent ﬂow, open
arrow) of the left ventricular outﬂow tract and causing mitral
regurgitation (thin arrow) by restricting anterior mitral valve
leaﬂet movement (Online Video 2). Abbreviations as in Figure 2.renal and liver function, Stroke, Bleeding, Labile
INRs, Elderly, Drugs or alcohol] score 4), he was a
good candidate for percutaneous LAA occlusion.
The LAA closure procedure has been described
elsewhere (1). Brieﬂy, after right femoral vein access a
transseptal puncture was performed. A Watchman
(Boston Scientiﬁc, Natick, Massachusetts) device
(27 mm) was positioned in the LAA, and it was
released after all release criteria were met.
The next day, the patient was asymptomatic and
hemodynamically stable. However, a routine elec-
trocardiogram showed new intermittent left bundle
branch block (Figure 1). The transthoracic and
transesophageal echocardiograms conﬁrmed the
suspected dislocation of the LAA device in the left
ventricular outﬂow tract (Figures 2 and 3, Online
Videos 1 and 2). He underwent a successful trans-
apical extraction of the device using a pulling
catheter position from the cardiac apex (Figure 4,
Online Video 3).
Dislocation of a Watchman device had been
described in 0.65% of cases in the PROTECT-AF
(Watchman Left Atrial Appendage System for
Embolic Protection in Patients With Atrial Fibrilla-
tion) trial and is an important procedural compli-
cation with possible severe consequences (2). Most
dislocations are silent and the device can generally
be traced in the abdominal aorta (3). Percutaneous
removal via the femoral artery is the treatment of
choice. In the present case, the device got attached
to the left ventricular outﬂow tract. The unfolded
anchoring barbs were hooked into the interven-
tricular septum and the anterior mitral valve leaﬂet
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e117causing mitral regurgitation. Therefore, a retro-
grade percutaneous extraction was considered un-
feasible because of the risk of damage to the aortic
and mitral valves, as described by Stöllberger
et al. (4).
This is the ﬁrst description of Watchman device
dislocation unmasked by intermittent left bundle
branch block. A Watchman device trapped in theleft ventricular outﬂow tract can be safely extracted
by the transapical approach.
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